Tracking a rare but deadly Poison's antidote
NCT ID NCT03569514
Summary
This study aims to learn about the safety and potential benefit of a treatment called AIGIV for people with severe, body-wide anthrax infections. It will collect information from up to 10 patients who receive this treatment as part of their standard medical care. The main goal is to see if the treatment helps patients survive and to monitor for any serious side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.